| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8790657 | American Journal of Ophthalmology | 2018 | 32 Pages |
Abstract
The majority of patients enjoyed a good visual outcome and achieved remission after aggressive treatment. Rituximab should be considered as an initial treatment for patients with refractory retinal vasculitis associated with AAV.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Miaoli Lin, Stephen D. Anesi, Lina Ma, Aseef Ahmed, Karen Small, C. Stephen Foster,